Influence of Angiotensin II Subtype 2 Receptor (AT2R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT1R) Blockade

Influence of Angiotensin II Subtype 2 Receptor (AT2R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT1R) Blockade

Cardiac AT2R expression is upregulated in the normal process of aging. In this study we determined the contribution of AT2R to chronic antihypertensive and remodelling effects of AT1R blockade in aged hypertensive rats. Adult (20 weeks) and senescent (20 months) spontaneously hypertensive rats (SHRs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Emma S. Jones, M. Jane Black, Robert E. Widdop
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2012/543062
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
by: Hajaralsadat Hosseini-Dastgerdi, et al.
Published: (2022-01-01)

The Angiotensin II Type 2 Receptor in Brain Functions: An Update
by: Marie-Odile Guimond, et al.
Published: (2012-01-01)

Molecular Modeling Studies of Substituted 2,4,5-Trisubstituted Triazolinones Aryl and Nonaryl Derivatives as Angiotensin II AT1 Receptor Antagonists
by: Mukesh C. Sharma, et al.
Published: (2013-01-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors
by: Gabriela Placoná Diniz, et al.
Published: (2010-01-01)

New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
by: Michelle A. Clark, et al.
Published: (2013-01-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01)

Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
by: Takuto Nakamura, et al.
Published: (2017-01-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Gender Difference in Renal Blood Flow Response to Angiotensin II Administration after Ischemia/Reperfusion in Rats: The Role of AT2 Receptor
by: Maryam Maleki, et al.
Published: (2016-01-01)

Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation
by: Shuang Lin, et al.
Published: (2022-01-01)

Interaction between Angiotensin II and Insulin/IGF-1 Exerted a Synergistic Stimulatory Effect on ERK1/2 Activation in Adrenocortical Carcinoma H295R Cells
by: An-li Tong, et al.
Published: (2016-01-01)

Angiotensin II and Renal Tubular Ion Transport
by: Patricia Valles, et al.
Published: (2005-01-01)

A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs
by: Lejing Qu, et al.
Published: (2025-01-01)

Biosynthetic Pathways and the Role of the Mas Receptor in the Effects of Angiotensin-(1–7) in Smooth Muscles
by: Marcio Augusto Fressatto de Godoy, et al.
Published: (2012-01-01)

KLF12 Aggravates Angiotensin II‐Induced Cardiac Remodeling in Male Mice by Transcriptionally Inhibiting SMAD7
by: Min Hu, et al.
Published: (2025-02-01)

Roles of Brain Angiotensin II in Cognitive Function and Dementia
by: Masaki Mogi, et al.
Published: (2012-01-01)

Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy
by: Leonid Maizels, et al.
Published: (2022-06-01)

Correlation and clinical significance of placental tissue selectin (E), angiotensin II and its receptors, and oxidized lipid levels in patients with preeclampsia
by: Yan Gao, et al.
Published: (2025-01-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014-01-01)

Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling
by: Yasuhiro Izumiya, et al.
Published: (2012-01-01)

GABA𝐀 Receptor Subtypes: Novel Targets for Novel Medicines
by: Naheed R. Mirza, et al.
Published: (2012-01-01)

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
by: Wei-Fan Hsu, et al.
Published: (2019-01-01)

Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients
by: Dae Wook Lee, et al.
Published: (2019-01-01)

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
by: Avantika Chenna, et al.
Published: (2020-01-01)

The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?
by: Wencheng Li, et al.
Published: (2012-01-01)

Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers
by: Simona Lattanzi, et al.
Published: (2013-01-01)

Angiotensin IV Receptors in the Rat Prefrontal Cortex: Neuronal Expression and NMDA Inhibition
by: Zsolt Tamás Papp, et al.
Published: (2024-12-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Therapeutic role of miR-26a on cardiorenal injury in a mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway
by: Weijie Ni, et al.
Published: (2025-01-01)

The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
by: Hanna Lawnicka, et al.
Published: (2012-01-01)

Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities”
by: Daniel Arthur B. Kasal, et al.
Published: (2012-01-01)

Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
by: Enéas R. M. Gomes, et al.
Published: (2012-01-01)

Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening
by: Beenish Majeed, et al.
Published: (2014-01-01)

Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
by: Tomoko Asagami, et al.
Published: (2011-01-01)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
by: Qi Feng, et al.
Published: (2020-01-01)

Angiotensin-Converting Enzyme 2: The First Decade
by: Nicola E. Clarke, et al.
Published: (2012-01-01)

Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1
by: Qingyuan Jiang, et al.
Published: (2021-01-01)